Siblings 圖書 [0/1] 專利 [0/14] Collection Statistics 近3年內發表的文件:5(10.64%) 含全文筆數:47(100.00%) 文件下載次數統計 下載大於0次:47(100.00%) 下載大於100次:46(97.87%) 檔案下載總次數:26849(100.00%) 最後更新時間: 2025-04-21 05:29 Top Upload Loading... Top Download Loading... Recent Submissions Enhanced construction of a bivalent... Hyperglycemia facilitates EV71 repl... The stability and immunogenicity of... Human SCARB2 acts as a cellular ass... Propagation and immunological chara... Separation and purification of high... SARS-CoV-2 spike protein enhances M... Neurotropic EV71 causes encephaliti... Induction of Th1 and Th2 in the pro... The mature EV71 virion induced a br...

Jump to a point in the index: (Choose year) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-47 of 47. (1 Page(s) Totally) 1  View [10|25|50] records per page

Date	Title	Relation
2025-04	Enhanced construction of a bivalent adenovirus-based vaccine for preventing childhood pathogens: Human respiratory syncytial virus and norovirus	SLAS Technology. 2025 Apr;31:Article number 100255.
2024-04-22	Hyperglycemia facilitates EV71 replication: Insights into miR-206-mediated regulation of G3BP2 promoting EV71 IRES activity	Theranostics. 2024 Apr 22;14(7):2706-2718.
2023-12	The stability and immunogenicity of formalin-inactivated Enterovirus A71 whole virion vaccine after ten years of low temperature storage	Journal of Microbiology, Immunology and Infection. 2023 Dec;56(6):1121-1128.
2023-04-08	Human SCARB2 acts as a cellular associator for helping coxsackieviruses A10 infection	Viruses. 2023 Apr 8;15(4):Article number 932.
2023-03-24	Propagation and immunological characterization of coxsackievirus A10 in a serum-free HEK293A cell culture system	Virus Research. 2023 Mar 24;329:Article number 199101.
2022-09-13	Separation and purification of highly infectious enterovirus A71 particles using a strong anion-exchange column	Journal of Chromatography A. 2022 Sep 13;1680:Article number 463427.
2022-07-27	SARS-CoV-2 spike protein enhances MAP4K3/GLK-induced ACE2 stability in COVID-19	EMBO Molecular Medicine. 2022 Jul 27:Article number e15904.
2022-04-11	Neurotropic EV71 causes encephalitis by engaging intracellular TLR9 to elicit neurotoxic IL12-p40-iNOS signaling	Cell Death and Disease. 2022 Apr 11;13:Article number 328.
2022-01-28	Induction of Th1 and Th2 in the protection against SARS-CoV-2 through mucosal delivery of an adenovirus vaccine expressing an engineered spike protein	Vaccine. 2022 Jan28;40(4):574-586.
2019-01	The mature EV71 virion induced a broadly cross-neutralizing VP1 antibody against subtypes of the EV71 virus	PLoS ONE. 2019 Jan;14(1):Article number e0210553.
2018-08	Maternal immunization with a recombinant adenovirus-expressing fusion protein protects neonatal cotton rats from respiratory syncytia virus infection by transferring antibodies via breast milk and placenta	Virology. 2018 Aug;521:181-189.
2018-07-16	A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge	Scientific Reports. 2018 Jul 16;8:Article number 10713.
2018-07	Therapeutic effect of repurposed temsirolimus in lung adenocarcinoma model	Frontiers in Pharmacology. 2018;9:Article number 778
2018-06-04	Mutations in VP1 and 5′-UTR affect enterovirus 71 virulence [Erratum: Scientific Reports. 2018 Apr 27;8(1):Article number 6688.]	Scientific Reports. 2018 Jun 4;8:Article number 8744.
2018-05	Enhancing enterovirus A71 vaccine production yield by microcarrier profusion bioreactor culture	Vaccine. 2018 May;36(22):3134-3139.
2018-04-27	Mutations in VP1 and 5′-UTR affect enterovirus 71 virulence	Scientific Reports. 2018 Apr 27;8(1):Article number 6688.
2017-04-18	Characterization of a transgenic mouse model exhibiting spontaneous lung adenocarcinomas with a metastatic phenotype	PLoS ONE. 2017 Apr 18;12(4):Article number e0175586.
2016-08	Insulin Receptor Substrate-1 activation mediated p53 downregulation protects against Hypoxic-Ischemia in the neonatal brain	Molecular Neurobiology. 2016 Aug;53(6):3658-3669.
2016-08	Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology	Antiviral Research. 2016 Aug;132:225-232.
2016-06	Immunogenicity of an adeno-vector vaccine expressing the F protein of a respiratory syncytial virus manufactured from serum-free suspension culture	Antiviral Research. 2016 Jun;130:27-35.
2016-05	Immunological and biochemical characterizations of Coxsackievirus A6 and A10 viral particles	Antiviral Research. 2016 May;129:58-66.
2015-12	Depletion of regulatory T-cells leads to moderate B-cell antigenicity in respiratory syncytial virus infection	International Journal of Infectious Diseases. 2015 Dec;41:56-64.
2015-08-19	Inactivated enterovirus 71 vaccine produced by 200-L scale serum-free microcarrier bioreactor system provides cross-protective efficacy in human SCARB2 transgenic mouse	PLoS ONE. 2015 Aug 19;10(8):Article number e0136420.
2015-04	Recombinant adeno-vaccine expressing Enterovirus 71-like particles against hand, foot, and mouth disease	PLoS Neglected Tropical Diseases. 2015 Apr;9(4):Article number e0003692.
2015-03	Review of enterovirus 71 vaccines	Clinical Infectious Diseases. 2015 Mar;60(5):797-803.
2014-10	Alleviation of respiratory syncytial virus replication and inflammation by fungal immunomodulatory protein FIP-fve from Flammulina velutipes	Antiviral Research. 2014 Oct;110:124-131.
2014-10	Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases	Vaccine. 2014 Oct;32(47):6177-6182.
2014-09-08	Long-term immunogenicity studies of formalin-inactivated Enterovirus 71 whole-virion vaccine in macaques	PLoS ONE. 2014 Sep 8;9(9):Article number e106756.
2014-09	Epstein-barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma	Oncotarget. 2014 Sep;5(18):8583-8601.
2014-06-11	Immunogenicity studies of bivalent Inactivated virions of EV71/CVA16 formulated with submicron emulsion systems	Biomed Research International. 2014 Jun 11;2014:Article number 670506.
2013-10-02	Heat Shock protein 90: Role in enterovirus 71 entry and assembly and potential target for therapy	PLoS ONE. 2013 Oct 2;8(10):Article number e77133.
2013-08	Caveolar endocytosis is required for human PSGL-1-mediated enterovirus 71 infection	Journal of Virology. 2013 Aug;7(16):9064-9076.
2013-07-30	Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice	PLoS ONE. 2013 Jul 30;8(7):Article number e69858.
2013-02-25	Human SCARB2 transgenic mice as an infectious animal model for Enterovirus 71	PLoS ONE. 2013 Feb 25;8(2):Article number e57591.
2012-12	Production of EV71 vaccine candidates	Human Vaccine Immunotherapy. 2012 Dec;8(12):1775-1783.
2012-09	Immunological evaluation and comparison of different EV71 vaccine candidates	Clinical and Developmental Immunology. 2012 Sep;2012:Article ID 831282.
2012-04	Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates	PLoS ONE. 2012 Apr;7(4):Article number e34834.
2012-01	Human SCARB2-Mediated entry and endocytosis of EV71	PLoS ONE. 2012 Jan;7(1):Article number e30507.
2011-09	Development of a quantitative enzyme linked immunosorbent assay for monitoring the Enterovirus 71 vaccine manufacturing process	Journal of Virological Methods. 2011 Sep;176(1-2):60-68.
2011-09	Immunoprotectivity of HLA-A2 CTL peptides derived from respiratory syncytial virus fusion protein in HLA-A2 transgenic mouse	PLoS ONE. 2011 Sep;6(9):Article number e25500.
2011-06	Identification and characterization of a cross-neutralization epitope of Enterovirus 71	Vaccine. 2011 Jun;29(26):4362-4372.
2011-05	Tonsillar CD4(+)FOXP3(+) T-regulatory cell dynamics in primary EBV infection	Immunologic Research. 2011 May;50(1):97-101.
2011-05	Generation of murine monoclonal antibodies which cross-neutralize human enterovirus genogroup B isolates	Journal of Virological Methods. 2011 May;173(2):189-195.
2010-08-02	Functional interaction between Env oncogene from Jaagsiekte sheep retrovirus and tumor suppressor Sprouty2	Retrovirology. 2010 Aug 2;7(1):62.
2009-10-10	Generation and characterization of JSRV envelope transgenic mice in FVB background	Virology. 2009 Oct 10;393(1):120-126.
2009-09-04	Immunogenic properties of RSV-B1 fusion (F) protein gene-encoding recombinant adenoviruses	Vaccine. 2009 Sep 4;27(40):5460-5471.
2007-06	The cross-regulatory relationship between human dendritic and regulatory T cells and its role in type 1 diabetes mellitus	Review of Diabetic Studies. 2007 Jun;4(2):68-76.

Showing items 1-47 of 47. (1 Page(s) Totally) 1  View [10|25|50] records per page